文献速递泌尿生殖妇产影像USCTMR

老年女性偶发卵巢囊肿的监测:按年龄和合并症水平评估最大预期获益

Surveillance in Older Women With Incidental Ovarian Cysts: Maximal Projected Benefits by Age and Comorbidity Level.
PubMed 文献 · J Am Coll Radiol · 2020-10-21

本研究用决策分析马尔可夫模型估算绝经后女性偶发单纯性卵巢囊肿影像监测对预期寿命的获益,按年龄66-80岁和合并症(无、轻、中、重)分层比较2年影像随访与不随访策略。在假设卵巢癌完美检出和治疗的条件下,随访带来的预期寿命增益有限:无合并症66岁女性为5.1天,80岁伴严重合并症者仅2.1天。

要点

  • 绝经后女性(≥66岁)单纯性卵巢囊肿影像随访的预期寿命增益有限,无合并症66岁女性最多5.1天。
  • 年龄越大、合并症越重,随访增益越小:80岁伴严重合并症者仅2.1天。
  • 即使假设囊肿患者癌症风险不升高且随访中可完美检出和治疗卵巢癌,获益仍有限。

诊断标准与关键数值

  • 无合并症女性随访预期寿命增益:66岁5.1天、70岁5.1天、75岁4.5天、80岁3.7天。
  • 严重合并症女性随访预期寿命增益:66岁3.5天、70岁3.2天、75岁2.7天、80岁2.1天。
  • 癌症检出敏感度50%时,无合并症66岁女性增益3.7天,严重合并症80岁女性增益1.3天。
  • 假设囊肿患者癌症风险为平均风险1.1倍时,相应队列增益仅轻度增加至5.6天和2.3天。

局限性

  • 模型假设随访期间卵巢癌完美检出和治疗,以估计理论最大预期寿命增益。
  • 未假设囊肿患者癌症风险升高,仅在敏感性分析中假设风险为平均1.1倍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to estimate effects on life expectancy (LE) of imaging-based ovarian surveillance after detection of incidental postmenopausal ovarian cysts, under different assumptions of patient age, comorbidity level, and cancer risk and detection.

METHODS: A decision-analytic Markov model was developed to estimate LE benefits. Hypothetical cohorts of postmenopausal women with simple ovarian cysts were evaluated, with varied age (66-80 years) and comorbidity level (none, mild, moderate, severe). For each cohort, imaging "follow-up" (2 years) and "no-follow-up" strategies were compared. Consistent with current evidence, increased cancer risk in patients with cysts was not assumed; however, incident ovarian cancers could be detected during follow-up. To estimate theoretical maximal LE gains from follow-up, perfect ovarian cancer detection and treatment during follow-up were assumed. This and other key assumptions were varied in sensitivity analysis.

RESULTS: Projected LE gains from follow-up were limited. For 66-, 70-, 75-, and 80-year-old women with no comorbidities, LE gains were 5.1, 5.1, 4.5, and 3.7 days; with severe comorbidities, they were 3.5, 3.2, 2.7, and 2.1 days. With sensitivity of 50% for cancer detection, they were 3.7 days for 66-year-old women with no comorbidities and 1.3 days for 80-year-old women with severe comorbidities. When cancer risk for women with cysts was assumed to be elevated (1.1 times average risk), LE gains increased only modestly (5.6 and 2.3 days for analogous cohorts).

CONCLUSIONS: Even in the circumstance of perfect ovarian cancer detection and treatment, surveillance of postmenopausal women (≥66 years of age) with simple cysts affords limited benefits, particularly in women with advanced age and comorbidities.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Seguin CL, Lietz AP, Wright JD, et al. Surveillance in Older Women With Incidental Ovarian Cysts: Maximal Projected Benefits by Age and Comorbidity Level. J Am Coll Radiol. 2020. PMID: 33096089. doi:10.1016/j.jacr.2020.09.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。